<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1605596</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2025.1605596</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Structural studies of bacteria and viruses</article-title>
<alt-title alt-title-type="left-running-head">Pastore</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2025.1605596">10.3389/fmolb.2025.1605596</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Pastore</surname>
<given-names>Annalisa</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/124901/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>The Wohl Institute, King&#x2019;s College London</institution>, <addr-line>London</addr-line>, <country> United Kingdom</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Elettra Sincrotrone Trieste</institution>, <addr-line>Basovizza</addr-line>, <country>Italy</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1459898/overview">Saraboji Kadhirvel</ext-link>, Central University of Punjab, India</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Annalisa Pastore, <email>annalisa.pastore@elettra.eu</email>; <email>annalisa.1.pastore@kcl.ac.uk</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>04</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="ecorrected">
<day>08</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>12</volume>
<elocation-id>1605596</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>04</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Pastore.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Pastore</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Mol. Biosci." xlink:href="https://www.frontiersin.org/research-topics/70719" ext-link-type="uri">Editorial on the Research Topic <article-title>Structural studies of bacteria and viruses</article-title>
</related-article>
<kwd-group>
<kwd>bacteria</kwd>
<kwd>virus</kwd>
<kwd>protein dynamic</kwd>
<kwd>pathogen biology</kwd>
<kwd>host interaction</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Structural Biology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>The nearly 2 years of secluded life imposed by the COVID-19 pandemia have probably made us all much more aware and sensitive than before to infections and their consequences: spread of the coronavirus emerged in Wuhan, China in December 2019 caused the acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the entire world and infected more than 88 million people, causing over 1.9 million deaths worldwide (<xref ref-type="bibr" rid="B2">WHO, 2020</xref>). In addition to mortality and health problems, the strict confinement, lockdown, and travel restrictions imposed by the pandemia in the attempt to reduce the spread of the contagion have resulted in an uncountable number of socio-economic implications (<xref ref-type="bibr" rid="B1">Mara et al., 2025</xref>). As a consequence of the non-trivial impact of COVID-19, new research has been dedicated to the study of viruses, boosting fields beyond that of COVID-19 and more in general of all pathogens and ways to counteract their harmful effect.</p>
<p>In the present Research Topic, we grouped articles that address different aspects of the structural biology of viruses and bacteria. Six papers appeared in Frontiers in 2022, three concerning viral proteins, and three more which concern bacterial proteins.</p>
<p>In the paper by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2021.807577">Mal&#xe4;r et al.</ext-link>, the authors used solid-state NMR to experimentally characterize the dynamics of the 3.5 MDa hepatitis B virus (HBV) capsid, assembled from 240 copies of the Cp149 core protein. By comparing the NMR relaxation parameters <italic>T</italic>
<sub>
<italic>1</italic>
</sub> and <italic>T</italic>
<sub>
<italic>1&#x3c1;</italic>
</sub> for the capsid protein, used as detectors of dynamics in the nanosecond and microsecond timescale, with values obtained from a 1 microseconds Molecular Dynamics trajectory, the authors could reconstruct the dynamics of the system showing a strong complementarity between the two methods.</p>
<p>In <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2021.811106">Chen et al.</ext-link>, the authors reported in the N-terminal RNA-binding domain (NTD) of the coronavirus N protein a potential allosteric site (Site 1) that modulates its conformation and identified by PARS, an online allosteric site predictor. N is a nucleocapsid protein that forms an oligomer and facilitates binding with the viral RNA genome. 5-hydroxyindole was proposed to target Site 1 based on molecular docking and, based on this knowledge, four 5-hydroxyindole derivatives were designed and synthesized. Two of these 5-hydroxyindole compounds with higher hydrophobic R-groups were shown by Small-Angle X-ray scattering (SAXS) to mediate the binding between the N- and C-terminal domains and promote further oligomerization of the whole N protein while forming a hydrophobic cavity, which mediates the interaction between the two domains. The study thus indicated an allosteric binding pocket that induces aggregation of the N protein and that may be targeted by anti-COVID drugs.</p>
<p>In the review by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2022.871499">Hsu et al.</ext-link>, the authors summarized recent structural and mutational characteristics of the RNA binding domain of the human coronavirus spike protein and of its interaction with specific human cell receptors and analysed the structural requirements and plasticity of the RNA binding domain. The study is interesting because the stability of the spike protein, affinity toward receptor, virus fitness, and infectivity are the factors controlling the viral tropisms. The authors argued that structural information about the spike protein and the receptors of human coronaviruses are the key to understand the molecular mechanism of host-microbe pathogenesis and can be used as the starting point to develop effective drugs to control infection in future coronavirus outbreaks.</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2022.923042">Ghosh et al.</ext-link> studied the protein 3-oxoacyl-[acyl-carrier-protein] reductase (FabG), a key component in the type II fatty acid synthase (FAS II) system from the gram-positive bacterium <italic>Streptococcus pneumoniae</italic>. FabG is responsible for various infections caused by the bacterium, and its antibiotic resistance presents significant challenges to medical treatment and is thus a target for new anti-streptococcal antibiotics. The authors solved the SpFabG structure by X-ray diffraction at 2 &#xc5; coadjuvated by AlphaFold models for molecular replacement. They also suggested that dimers rather than the crystallographic tetramer could be the active conformation in solution although formation of the tetramer of is important for the enzyme activity. By comparing the structures of FabG homologues, the conserved tetramerization site was identified. Finally, a thorough pharmacophore-based virtual screening study using a vast library of compounds (533,600 small molecules), supplemented by molecular docking and binding energy calculations, identified three promising candidates for SpFabG inhibition.</p>
<p>The review by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2022.930931">Li et al.</ext-link> are discussed recent advances in the understanding of the relationships between structure, function, and allosteric regulation of the tryptophan synthase (TS) complex from <italic>Salmonella typhimurium.</italic> The synthesis of L-tryptophan (L-Trp) in enteric bacteria initiates at the level of gene expression by controlling the expression of the five enzymes of the Trp operon responsible for the L-Trp synthesis by the L-Trp cellular concentration. Two of these enzymes, trpA and trpB, form the &#x3b1;&#x3b2;&#x3b2;&#x3b1; TS complex which is responsible for the last two enzymatic processes in the L-Trp synthesis. The authors details all the steps in which the TS system is involved and argue that the complex provides an unusual example of allosteric control.</p>
<p>Finally, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2024.1472252">Xu et al.</ext-link> determined the structures of enolase enzymes from <italic>Mycoplasma pneumoniae</italic> and <italic>Mycoplasma bovis</italic>. Mycoplasmas are a genus of bacteria that lack a cell wall, and its cell membrane peptidoglycan layer and are thought to be constantly in a rapid evolution. Enolases are enzyme central in glycolysis. The authors found that <italic>mycoplasma</italic> enolases contain an extra helix that contains F-K/G-K-L/F-K-X-A-I motifs. Comparison between the two enolase enzymes suggested a divergent evolution of <italic>mycoplasma</italic> enolases. Overall, these results provided the first direct proof of a rapid and divergent evolution of <italic>mycoplasma</italic> enolases. This study will help understanding the independent evolution of <italic>Mycoplasma</italic> species after separation from a common ancestor.</p>
<p>Overall, the six papers of this RT provide an overview of the most recent achievements made in the ever growing field of Structural Biology.</p>
</body>
<back>
<sec sec-type="author-contributions" id="s1">
<title>Author contributions</title>
<p>AP: Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s2">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research and/or publication of this article.</p>
</sec>
<sec sec-type="COI-statement" id="s3">
<title>Conflict of interest</title>
<p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s4">
<title>Correction note</title>
<p>A correction has been made to this article. Details can be found at: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2025.1697351">10.3389/fmolb.2025.1697351</ext-link>.</p>
</sec>
<sec sec-type="ai-statement" id="s5">
<title>Generative AI statement</title>
<p>The authors declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s6">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mara</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cotoraci</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Impact of pulmonary comorbidities on COVID-19: acute and long-term evaluations</article-title>. <source>J. Clin. Med.</source> <volume>14</volume> (<issue>5</issue>), <fpage>1446</fpage>. <pub-id pub-id-type="doi">10.3390/jcm14051446</pub-id>
<pub-id pub-id-type="pmid">40094893</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="book">
<collab>WHO</collab> (<year>2020</year>). <source>COVID-19 dashboard</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://covid19.who.int/">https://covid19.who.int/</ext-link>.</comment>
</citation>
</ref>
</ref-list>
</back>
</article>